RDInvesting Provides Investors with Free In-Depth Equity Reports on ARIA, DYAX, GERN and T

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA - News) shares increased 2.11 percent to close at $7.76 a share Tuesday. The stock traded between $7.58 and $7.98 on volume of 10.13 million shares traded. Analysts at H.C. Wainwright have recently upgraded the company's rating to "buy" from "neutral". Shares of Ariad Pharmaceuticals have gained approximately 14.0 percent year-to-date.

Find out more about Ariad Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/ARIA

Dyax Corp. (NASDAQ:DYAX - News) shares increased 3.0 percent to close at $8.94 a share Tuesday. The stock traded between $8.64 and $9.48 on volume of 2.78 million shares traded. Analysts at RBC Capital have recently initiated coverage on the company with an "outperform" rating and a price target of $15.00. Shares of Dyax have gained approximately 18.0 percent year-to-date.

Find out more about Dyax including full access to the free equity report at:
www.RDInvesting.com/DYAX

Geron Corporation (NASDAQ:GERN - News) shares fell 5.70 percent to close at $2.15 a share Tuesday. The stock traded between $2.06 and $2.31 on volume of 6.78 million shares traded. Analysts at Piper Jaffray have recently downgraded the company's rating to "neutral" from "overweight". Shares of Geron have fallen approximately 55.0 percent year-to-date.

Find out more about Geron including full access to the free equity report at:
www.RDInvesting.com/GERN

AT&T Inc. (NYSE:T - News) shares increased 0.75 percent to close at $34.72 a share Tuesday. The stock traded between $34.37 and $34.89 on volume of 33.41 million shares traded. Analysts at HSBC have recently downgraded the company's rating to "neutral" from "overweight". Shares of AT&T have fallen approximately 1.25 percent year-to-date.

Find out more about AT&T including full access to the free equity report at:
www.RDInvesting.com/T

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com